stars 1 stars 2 stars 3

We are providing electronically activated purification of biomolecules for biopharmaceutical and protein production. By utilizing our patent-pending invention, we build functionalized polymer surfaces that can with high specificity and high capacity capture and release biomolecules at the press of a button. Making today's complex biopharmaceutical and protein manufacturing simpler, more effective, and digital.

Nyctea Technologies Questions

Gustav Ferrand-Drake is the Co-founder, CEO, and member of the board of Nyctea Technologies.

6 people are employed at Nyctea Technologies.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users